Characterizations of angiotensin-converting enzyme-2 (ACE2) peptidase activity DOI
N. Saulnier,

Devyn M. Thorne,

Fariha E Bablu

et al.

Archives of Biochemistry and Biophysics, Journal Year: 2024, Volume and Issue: 761, P. 110167 - 110167

Published: Sept. 28, 2024

Language: Английский

Synthesis, molecular docking, and in vitro activity of a novel angiotensin-converting enzyme 2 inhibitor, LMS1007: a potential molecule in Covid-19 and cancer treatments DOI Creative Commons
Loai M. Saadah, Ghina’a Abu Deiab, Qosay Al‐Balas

et al.

RSC Advances, Journal Year: 2025, Volume and Issue: 15(19), P. 15138 - 15154

Published: Jan. 1, 2025

Angiotensin-converting enzyme 2 (ACE2) is a validated common protein in the pathology of several diseases, including novel coronavirus and breast cancer.

Language: Английский

Citations

0
Characterizations of angiotensin-converting enzyme-2 (ACE2) peptidase activity DOI
N. Saulnier,

Devyn M. Thorne,

Fariha E Bablu

et al.

Archives of Biochemistry and Biophysics, Journal Year: 2024, Volume and Issue: 761, P. 110167 - 110167

Published: Sept. 28, 2024

Language: Английский

Citations

0